| An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities EB Kaminsky, V Kaul, J Paschall, DM Church, B Bunke, D Kunig, ... Genetics in medicine 13 (9), 777-784, 2011 | 530 | 2011 |
| HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium RN Pillai, M Behera, LD Berry, MR Rossi, MG Kris, BE Johnson, PA Bunn, ... Cancer 123 (21), 4099-4105, 2017 | 381 | 2017 |
| Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01 AB Lassman, MR Rossi, JR Razier, LE Abrey, FS Lieberman, CN Grefe, ... Clinical cancer research 11 (21), 7841-7850, 2005 | 289 | 2005 |
| The impact of smoking and TP53 mutations in lung adenocarcinoma patients with targetable mutations—the Lung Cancer Mutation Consortium (LCMC2) DL Aisner, LM Sholl, LD Berry, MR Rossi, H Chen, J Fujimoto, AL Moreira, ... Clinical Cancer Research 24 (5), 1038-1047, 2018 | 219 | 2018 |
| The immortalized UROtsa cell line as a potential cell culture model of human urothelium MR Rossi, JR Masters, S Park, JH Todd, SH Garrett, MA Sens, S Somji, ... Environmental health perspectives 109 (8), 801, 2001 | 182 | 2001 |
| Metabolic rewiring by oncogenic BRAF V600E links ketogenesis pathway to BRAF-MEK1 signaling HB Kang, J Fan, R Lin, S Elf, Q Ji, L Zhao, L Jin, JH Seo, C Shan, ... Molecular cell 59 (3), 345-358, 2015 | 172 | 2015 |
| Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium CE Steuer, M Behera, L Berry, S Kim, M Rossi, G Sica, TK Owonikoko, ... Cancer 122 (5), 766-772, 2016 | 124 | 2016 |
| Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer TK Owonikoko, G Zhang, HS Kim, RM Stinson, R Bechara, C Zhang, ... Journal of translational medicine 14 (1), 111, 2016 | 107 | 2016 |
| Critical role of ASCT2-mediated amino acid metabolism in promoting leukaemia development and progression F Ni, WM Yu, Z Li, DK Graham, L Jin, S Kang, MR Rossi, S Li, ... Nature metabolism 1 (3), 390-403, 2019 | 105 | 2019 |
| Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancer TK Owonikoko, G Zhang, X Deng, MR Rossi, JM Switchenko, GH Doho, ... Cancer medicine 3 (6), 1579-1594, 2014 | 99 | 2014 |
| Molecular characterization of the t (3; 9) associated with immortalization in the MCF10A cell line JK Cowell, J LaDuca, MR Rossi, T Burkhardt, NJ Nowak, S Matsui Cancer genetics and cytogenetics 163 (1), 23-29, 2005 | 90 | 2005 |
| Defining the expression pattern of the LGI1 gene in BAC transgenic mice K Head, S Gong, S Joseph, C Wang, T Burkhardt, MR Rossi, J LaDuca, ... Mammalian Genome 18 (5), 328-337, 2007 | 82 | 2007 |
| HER3 targeting sensitizes HNSCC to cetuximab by reducing HER3 activity and HER2/HER3 dimerization: evidence from cell line and patient-derived xenograft models D Wang, G Qian, H Zhang, KR Magliocca, S Nannapaneni, ARMR Amin, ... Clinical Cancer Research 23 (3), 677-686, 2017 | 75 | 2017 |
| Array CGH analysis of pediatric medulloblastomas MR Rossi, J Conroy, D McQuaid, NJ Nowak, JT Rutka, JK Cowell Genes, Chromosomes and Cancer 45 (3), 290-303, 2006 | 71 | 2006 |
| A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors AS Mansfield, DS Hong, CL Hann, AF Farago, H Beltran, SN Waqar, ... NPJ precision oncology 5 (1), 74, 2021 | 69 | 2021 |
| Clinical validation and implementation of a targeted next-generation sequencing assay to detect somatic variants in non-small cell lung, melanoma, and gastrointestinal malignancies KE Fisher, L Zhang, J Wang, GH Smith, S Newman, TM Schneider, ... The Journal of Molecular Diagnostics 18 (2), 299-315, 2016 | 68 | 2016 |
| Expression of hsp 27, hsp 60, hsc 70, and hsp 70 stress response genes in cultured human urothelial cells (UROtsa) exposed to lethal and sublethal concentrations of sodium arsenite MR Rossi, S Somji, SH Garrett, MA Sens, J Nath, DA Sens Environmental health perspectives 110 (12), 1225, 2002 | 68 | 2002 |
| Identification of inactivating mutations in the JAK1, SYNJ2, and CLPTM1 genes in prostate cancer cells using inhibition of nonsense-mediated decay and microarray analysis MR Rossi, L Hawthorn, J Platt, T Burkhardt, JK Cowell, Y Ionov Cancer genetics and cytogenetics 161 (2), 97-103, 2005 | 67 | 2005 |
| Clinical and genomic characterization of distal duplications and deletions of chromosome 4q: study of two cases and review of the literature MR Rossi, MS DiMaio, B Xiang, K Lu, H Kaymakcalan, M Seashore, ... American Journal of Medical Genetics Part A 149 (12), 2788-2794, 2009 | 61 | 2009 |
| Colon carcinoma cells harboring PIK3CA mutations display resistance to growth factor deprivation induced apoptosis J Wang, K Kuropatwinski, J Hauser, MR Rossi, Y Zhou, A Conway, ... Molecular cancer therapeutics 6 (3), 1143-1150, 2007 | 61 | 2007 |
